Net Cash Provided by (Used in) Financing Activities in USD of Bone Biologics Corp from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Bone Biologics Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2025.
  • Bone Biologics Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $348K, a 76.9% decline year-over-year.
  • Bone Biologics Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was $4.42M, a 12.3% decline from 2023.
  • Bone Biologics Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $5.04M, a 13.9% increase from 2022.
  • Bone Biologics Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was $4.43M, a 44% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Bone Biologics Corp Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $348K -$1.16M -76.9% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q1 2024 $1.5M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q1 2021 $199K +$71K +55.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2020 $128K -$572K -81.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-21
Q1 2019 $700K +$200K +40% Jan 1, 2019 Mar 31, 2019 10-Q 2021-04-15
Q1 2018 $500K -$1.5M -75% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q1 2017 $2M -$3.63M -64.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q1 2016 $5.63M Jan 1, 2016 Mar 31, 2016 10-K 2018-04-02
Q4 2013 $1.25M +$1.25M Nov 1, 2013 Jan 31, 2014 10-Q 2014-03-17
Q4 2012 $0 $0 Nov 1, 2012 Jan 31, 2013 10-Q 2013-03-18
Q4 2011 $0 Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-18

Bone Biologics Corp Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.42M -$621K -12.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-26
2023 $5.04M +$614K +13.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-26
2022 $4.43M -$3.47M -44% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-21
2021 $7.9M +$7.5M +1862% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $403K -$1.92M -82.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $2.32M -$2.05M -46.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-15
2018 $4.37M +$970K +28.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 $3.4M -$3.43M -50.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 $6.83M +$4.83M +242% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $2M -$3.39M -62.9% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 $5.39M +$4.87M +928% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-28
2013 $525K +$518K +7900% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
2012 $6.56K +$2.96K +82.3% Nov 1, 2011 Oct 31, 2012 10-K 2014-02-13
2011 $3.6K -$2.08K -36.7% Nov 1, 2010 Oct 31, 2011 10-K 2013-01-29
2010 $5.68K Nov 1, 2009 Oct 31, 2010 10-K 2012-01-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.